Corrigendum to: Long-term outcomes of trans-oral robotic surgery-assisted total laryngectomy for recurrent laryngeal cancers

Background. The optimal radical surgical approach for rectal neuroendocrine tumor (NET) is unknown. Methods. This study evaluated the short- and long-term outcomes of 27 patients who underwent robotic radical surgery for rectal NET between 2011 and 2019. Results. The median distance from the lower border of the tumor to the anal verge was 5.0 cm. The median tumor size was 9.5 mm. Six patients (22%) had lymph node metastasis. The incidences of postoperative complications of grade II and grade III or more according to the Clavien–Dindo classification were 11% and 0%, respectively. All patients underwent sphincter-preserving surgery, and no patients required conversion to open surgery. The median follow-up time was 48.9 months, and both the 3-year overall survival and relapse-free survival rates were 100%. Conclusions. Short- and long-term outcomes of robotic surgery for rectal NET tumor were favorable. Robotic surgery may be a useful surgical approach for rectal NET.

Download Full-text

Robotic versus laparoscopic gastrectomy for gastric cancer: a systematic review and meta-analysis

World Journal of Surgical Oncology ◽

10.1186/s12957-020-02080-7 ◽

2020 ◽

Vol 18 (1) ◽

Author(s):

Jianglei Ma ◽

Xiaoyao Li ◽

Shifu Zhao ◽

Ruifu Zhang ◽

Dejun Yang

Keyword(s):

Gastric Cancer ◽

Systematic Review ◽

Robotic Surgery ◽

Laparoscopic Gastrectomy ◽

Resection Margin ◽

Meta Analysis ◽

Long Term Outcomes ◽

Short Term ◽

Meta Analyses

Abstract Background To date, robotic surgery has been widely used worldwide. We conducted a systematic review and meta-analysis to evaluate short-term and long-term outcomes of robotic gastrectomy (RG) in gastric cancer patients to determine whether RG can replace laparoscopic gastrectomy (LG). Methods The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement was applied to perform the study. Pubmed, Cochrane Library, WanFang, China National Knowledge Infrastructure (CNKI), and VIP databases were comprehensively searched for studies published before May 2020 that compared RG with LG. Next, two independent reviewers conducted literature screening and data extraction. The quality of the literature was assessed using the Newcastle-Ottawa Scale (NOS), and the data analyzed using the Review Manager 5.3 software. Random effects or fixed effects models were applied according to heterogeneity. Results A total of 19 studies including 7275 patients were included in the meta-analyses, of which 4598 patients were in the LG group and 2677 in the RG group. Compared with LG, RG was associated with longer operative time (WMD = −32.96, 95% CI −42.08 ~ −23.84, P < 0.001), less blood loss (WMD = 28.66, 95% CI 18.59 ~ 38.73, P < 0.001), and shorter time to first flatus (WMD = 0.16 95% CI 0.06 ~ 0.27, P = 0.003). There was no significant difference between RG and LG in terms of the hospital stay (WMD = 0.23, 95% CI −0.53 ~ 0.98, P = 0.560), overall postoperative complication (OR = 1.07, 95% CI 0.91 ~ 1.25, P = 0.430), mortality (OR = 0.67, 95% CI 0.24 ~ 1.90, P = 0.450), the number of harvested lymph nodes (WMD = −0.96, 95% CI −2.12 ~ 0.20, P = 0.100), proximal resection margin (WMD = −0.10, 95% CI −0.29 ~ 0.09, P = 0.300), and distal resection margin (WMD = 0.15, 95% CI −0.21 ~ 0.52, P = 0.410). No significant differences were found between the two treatments in overall survival (OS) (HR = 0.95, 95% CI 0.76 ~ 1.18, P = 0.640), recurrence-free survival (RFS) (HR = 0.91, 95% CI 0.69 ~ 1.21, P = 0.530), and recurrence rate (OR = 0.90, 95% CI 0.67 ~ 1.21, P = 0.500). Conclusions The results of this study suggested that RG is as acceptable as LG in terms of short-term and long-term outcomes. RG can be performed as effectively and safely as LG. Moreover, more randomized controlled trials comparing the two techniques with rigorous study designs are still essential to evaluate the value of the robotic surgery for gastric cancer.

Download Full-text

Commentary on: Robotic surgery for gastric cancer in the west: A systematic review and meta-analyses of short-and long-term outcomes

International Journal of Surgery ◽

10.1016/j.ijsu.2020.10.009 ◽

2020 ◽

Vol 84 ◽

pp. 51-52

Author(s):

Fernando A.M. Herbella ◽

Leonardo M. Del Grande

Keyword(s):

Gastric Cancer ◽

Systematic Review ◽

Robotic Surgery ◽

Long Term Outcomes ◽

The West ◽

Short And Long Term ◽

Meta Analyses

Download Full-text

Short- and long-term outcomes of robotic surgery for rectal cancer: a single-center retrospective cohort study

Surgery Today ◽

10.1007/s00595-019-01874-x ◽

2019 ◽

Vol 50 (3) ◽

pp. 240-247 ◽

Cited By ~ 1

Author(s):

Hidetoshi Katsuno ◽

Tsunekazu Hanai ◽

Koji Masumori ◽

Yoshikazu Koide ◽

Hiroshi Matsuoka ◽

...

Keyword(s):

Rectal Cancer ◽

Cohort Study ◽

Robotic Surgery ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Single Center ◽

Long Term Outcomes ◽

Short And Long Term

Download Full-text

Robotic surgery in gynecology

Orvosi Hetilap ◽

10.1556/oh.2012.29373 ◽

2012 ◽

Vol 153 (25) ◽

pp. 967-972

Author(s):

Roland Csorba

Keyword(s):

Robotic Surgery ◽

Gynecologic Oncology ◽

Surgical Approaches ◽

Long Term Outcomes ◽

Post Operative Pain ◽

Surgical Methods ◽

Adnexal Surgery ◽

The Right ◽

Oncologic Diseases

Minimally invasive surgery has revolutionized gynecological interventions over the past 30 years. The introduction of the da Vinci robotic surgery in 2005 has resulted in large changes in surgical management. The robotic platform allows less experienced laparoscopic surgeons to perform more complex procedures. It can be utilized mainly in general gynecology and reproductive gynecology. The robot is being increasingly used for procedures such as hysterectomy, myomectomy, adnexal surgery, and tubal anastomosis. In urogynecology, the robot is being utilized for sacrocolopexy as well. In the field of gynecologic oncology, the robot is being increasingly used for hysterectomy and lymphadenectomy in oncologic diseases. Despite the rapid and widespread adaption of robotic surgery in gynecology, there are no randomized trials comparing its efficacy and safety to other traditional surgical approaches. This article presents the development, technical aspects and indications of robotic surgery in gynecology, based on the previously published reviews. Robotic surgery can be highly advantageous with the right amount of training, along with appropriate patient selection. Patients will have less blood loss, less post-operative pain, faster recovery, and fewer complications compared to open surgery and laparoscopy. However, until larger randomized control trials are completed which report long-term outcomes, robotic surgery cannot be stated to have priority over other surgical methods. Orv. Hetil., 2012, 153, 967–972.

Download Full-text

Endometrial carcinoma: The perioperative and long-term outcomes of robotic surgery in the morbidly obese

Journal of Surgical Oncology ◽

10.1002/jso.24417 ◽

2016 ◽

Vol 114 (7) ◽

pp. 884-887 ◽

Cited By ~ 11

Author(s):

Shirley J. Hinshaw ◽

Stephanie Gunderson ◽

Daniel Eastwood ◽

William H. Bradley

Keyword(s):

Robotic Surgery ◽

Endometrial Carcinoma ◽

Morbidly Obese ◽

Long Term Outcomes

Download Full-text

Robotic surgery for clinical T4 rectal cancer: short- and long-term outcomes

Surgical Endoscopy ◽

10.1007/s00464-020-08241-9 ◽

2021 ◽

Author(s):

Yusuke Yamaoka ◽

Akio Shiomi ◽

Hiroyasu Kagawa ◽

Hitoshi Hino ◽

Shoichi Manabe ◽

...

Keyword(s):

Rectal Cancer ◽

Robotic Surgery ◽

Long Term Outcomes ◽

Short And Long Term

Download Full-text

Long‐term outcomes in patients with recurrent human papillomavirus‐positive oropharyngeal cancer after upfront transoral robotic surgery

Head & Neck ◽

10.1002/hed.26396 ◽

2020 ◽

Vol 42 (12) ◽

pp. 3490-3496

Author(s):

William Su ◽

Greeshma Rajeev‐Kumar ◽

Martin Kang ◽

Marshall Posner ◽

Jerry T. Liu ◽

...

Keyword(s):

Human Papillomavirus ◽

Robotic Surgery ◽

Oropharyngeal Cancer ◽

Transoral Robotic Surgery ◽

Long Term Outcomes

Download Full-text

Robotic Versus Laparoscopic Gastrectomy for Gastric Cancer: A Systematic Review and Meta-Analysis

10.21203/rs.3.rs-84003/v1 ◽

2020 ◽

Author(s):

Jianglei Ma ◽

Xiaoyao Li ◽

Shifu Zhao ◽

Ruifu Zhang ◽

Dejun Yang

Keyword(s):

Gastric Cancer ◽

Systematic Review ◽

Robotic Surgery ◽

Laparoscopic Gastrectomy ◽

Resection Margin ◽

Meta Analysis ◽

Cochrane Library ◽

Long Term Outcomes ◽

Significant Difference

Abstract Background To date, robotic surgery has been widely used worldwide. We conducted a systematic review and meta-analysis to evaluate short- and long-term outcomes of robotic gastrectomy (RG) in gastric cancer patients to determine whether RG can replace laparoscopic gastrectomy (LG).Methods Pubmed, Cochrane Library, WanFang, China National Knowledge Infrastructure (CNKI) and VIP databases were comprehensively searched for studies published before May 2020 that compared RG with LG. Next, two independent reviewers conducted literature screening and data extraction. The quality of the literature was assessed using the Newcastle-Ottawa Scale (NOS),and the data analyzed using the Review Manager 5.3 software. Random effects or fixed effects models were applied according to heterogeneity.Results A total of 19 studies including 7275 patients were included in the meta-analyses, of which 4598 patients were in the LG group and 2677 in the RG group. Compared with LG,RG was associated with longer operative time (WMD=−32.96 min; 95% CI:-42.08~-23.84, P<0.00001),less blood loss (WMD=28.66 ml; 95% CI: 18.59~38.73, P<0.00001),and shorter time to first flatus (WMD=0.16days; 95%CI:0.06~0.27, P=0.003).There was no significant difference between RG and LG in terms of the hospital stay (WMD=0.23days, 95 % CI:-0.53~0.98, P=0.56),overall postoperative complication (OR=1.07, 95 % CI:0.91~1.25, P=0.43),mortality (OR=0.67, 95% CI=0.24~1.90, P=0.45),the number of harvested lymph nodes (WMD=-0.96, 95% CI:-2.12~0.20, P=0.10),proximal resection margin (WMD=-0.10 cm,95% CI:-0.29~0.09, P=0.30),and distal resection margin (WMD=0.15cm,95% CI:-0.21~0.52, P=0.41).No significant differences were found between the two treatments in overall survival(OS) (HR=0.95, 95% CI:0.76~1.18; P=0.64), recurrence-free survival(RFS) (HR=0.91, 95% CI:0.69~1.21;P=0.53), and recurrence rate (OR=0.90, 95% CI:0.67~1.21; P=0.50). Conclusions The results of this study suggested that RG is as acceptable as LG in terms of short-term and long-term outcomes. RG can be performed as effectively and safely as LG. Moreover, more randomized controlled trials comparing the two techniques with rigorous study designs are still essential to evaluate the value of the robotic surgery for gastric cancer.

Download Full-text